Similar articles

• Retraction: 'Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke' by J. Iwamoto, T. Takeda and H. Matsumoto.

  [No authors listed] [No authors listed] Acta Neurol Scand. 2018 Jun;137(6):630. doi: 10.1111/ane.12940. Epub 2018 Mar 30. Acta Neurol Scand. 2018. PMID: 29732540
• Retraction: 'Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: A randomized controlled trial,' by Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K.

  [No authors listed] [No authors listed] Mov Disord. 2016 Jul;31(7):1077. doi: 10.1002/mds.26699. Epub 2016 Jun 6. Mov Disord. 2016. PMID: 27374761
• Statement of Concern Regarding: Sato Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a Predictive Factor for Hip Fracture in Elderly Women with Parkinson's Disease. Am J Med. 2005;118:1250-1255.

  Alpert JS. Alpert JS. Am J Med. 2018 Mar;131(3):e109. doi: 10.1016/j.amjmed.2017.11.022. Am J Med. 2018. PMID: 29454423 No abstract available.
• Article retraction. Sato Y, Honda Y, Iwamoto J, Amano N. Comparison of non-vertebral fracture between minodronate and risedronate therapy in elderly female patients with Alzheimer disease. J Musculoskelet Neuronal Interact 2013;13:346-52.

  [No authors listed] [No authors listed] J Musculoskelet Neuronal Interact. 2016 Sep 7;16(3):264. J Musculoskelet Neuronal Interact. 2016. PMID: 27609042 No abstract available.
• Retraction Statement.

  [No authors listed] [No authors listed] Eur Neurol. 2018;79(3-4):229. doi: 10.1159/000488922. Epub 2018 Apr 27. Eur Neurol. 2018. PMID: 31344700